Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Parul Sharma

Showing results (151-160 of 166) with videos related to

Pageof 17
Sort By:
Cancer Management and Research|June 23, 2025
A Retrospective Analysis Comparing the Dosimetric Parameters of Two Rectum-Sparing Techniques During Intracavitary Brachytherapy with Tandem-Ring Applicators for Cervical CancerSiddharth Vats, Shabnum Thakur, Manish Gupta, et al.
The EMBO Journal|February 15, 2021
Non-canonical autophagy functions of ATG16L1 in epithelial cells limit lethal infection by influenza A virusYingxue Wang, Parul Sharma, Matthew Jefferson, et al.
Iscience|January 23, 2024
Hypoxia inducible factors inhibit respiratory syncytial virus infection by modulation of nucleolin expressionXiaodong Zhuang, Giulia Gallo, Parul Sharma, et al.
Open Biology|June 5, 2024
Structural and functional characterization of nanobodies that neutralize Omicron variants of SARS-CoV-2Katy Cornish, Jiandong Huo, Luke Jones, et al.
Viruses|June 27, 2024
Sequential Infection with Influenza A Virus Followed by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Leads to More Severe Disease and Encephalitis in a Mouse Model of COVID-19Jordan J Clark, Rebekah Penrice-Randal, Parul Sharma, et al.
Frontiers in Immunology|October 30, 2024
Pulmonary SARS-CoV-2 infection leads to para-infectious immune activation in the brainCordelia Dunai, Claire Hetherington, Sarah A Boardman, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2025
An ultra-long heavy chain bovine antibody neutralizes SARS-CoV-2 and reacts broadly with sarbecovirusesTheocharis Tsoleridis, Chengcheng Fan, Emily J Park, et al.
Nature Communications|June 16, 2023
Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit SARS-CoV-2Katherine U Gaynor, Marina Vaysburd, Maximilian A J Harman, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|April 22, 2024
The IRE1α-XBP1 arm of the unfolded protein response is a host factor activated in SARS-CoV-2 infectionJose Javier Fernández, Arturo Marín, Romel Rosales, et al.
Nature Communications|September 23, 2021
A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19Jiandong Huo, Halina Mikolajek, Audrey Le Bas, et al.
Pageof 17

Showing results (151-160 of 166) with videos related to

Sort By:
Pageof 17
Cancer Management and Research|June 23, 2025
A Retrospective Analysis Comparing the Dosimetric Parameters of Two Rectum-Sparing Techniques During Intracavitary Brachytherapy with Tandem-Ring Applicators for Cervical CancerSiddharth Vats, Shabnum Thakur, Manish Gupta, et al.
The EMBO Journal|February 15, 2021
Non-canonical autophagy functions of ATG16L1 in epithelial cells limit lethal infection by influenza A virusYingxue Wang, Parul Sharma, Matthew Jefferson, et al.
Iscience|January 23, 2024
Hypoxia inducible factors inhibit respiratory syncytial virus infection by modulation of nucleolin expressionXiaodong Zhuang, Giulia Gallo, Parul Sharma, et al.
Open Biology|June 5, 2024
Structural and functional characterization of nanobodies that neutralize Omicron variants of SARS-CoV-2Katy Cornish, Jiandong Huo, Luke Jones, et al.
Viruses|June 27, 2024
Sequential Infection with Influenza A Virus Followed by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Leads to More Severe Disease and Encephalitis in a Mouse Model of COVID-19Jordan J Clark, Rebekah Penrice-Randal, Parul Sharma, et al.
Frontiers in Immunology|October 30, 2024
Pulmonary SARS-CoV-2 infection leads to para-infectious immune activation in the brainCordelia Dunai, Claire Hetherington, Sarah A Boardman, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2025
An ultra-long heavy chain bovine antibody neutralizes SARS-CoV-2 and reacts broadly with sarbecovirusesTheocharis Tsoleridis, Chengcheng Fan, Emily J Park, et al.
Nature Communications|June 16, 2023
Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit SARS-CoV-2Katherine U Gaynor, Marina Vaysburd, Maximilian A J Harman, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|April 22, 2024
The IRE1α-XBP1 arm of the unfolded protein response is a host factor activated in SARS-CoV-2 infectionJose Javier Fernández, Arturo Marín, Romel Rosales, et al.
Nature Communications|September 23, 2021
A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19Jiandong Huo, Halina Mikolajek, Audrey Le Bas, et al.
Pageof 17